All you have to do is ask the company or analysts about reimbursement to see where NUVA is heading. Right into the ditch. The analysts (and NUVA) may be hiding it, but the numbers speak for thmeselves.
And the distribution channel is a joke. The company is trying to make it look as though they have distributors. But for the most part, from the information I can gather from those thast watch this company closely, the channel is failing.
Watch out here everyone, this one is headed south in a hurry when the truth comes out. I smell a lawsuit.